News
18h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...
6d
Green Matters on MSNCOVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects RevealedA half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
The Associated Press on MSN12d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results